-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Studies have shown that patients with asthma are at risk of severe new coronary pneumonia , but it is unclear whether the asthma phenotype is related to new coronary pneumonia
Studies have shown that patients with asthma are at risk of severe new coronary pneumonia , but it is unclear whether the asthma phenotype is related to new coronary pneumonia
Researchers use the clinical practice research data link (CPRD) and match it with the general population
Researchers use the clinical practice research data link (CPRD) and match it with the general population
The results showed that the asthma cohort had 434348 asthma patients and 748327 matched general patients, and the allergic rhinitis cohort had 41890 allergic rhinitis patients and 115357 matched general population
The results showed that severe asthma is related to the outcome of severe new coronary pneumonia, but the type 2 inflammatory phenotype is not related to it
Original source:
Chloe I Bloom, Paul Cullinan, Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study , American Journal of Respiratory and Critical Care Medicine, 2021, https://doi.
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study
Leave a message here